Artera is a leading precision medicine company developing AI tests to personalize therapy for cancer patients. Their test provides risk stratification and prediction of therapeutic benefit, including the first-ever predictive test for localized prostate cancer.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/21/23 | $90,000,000 | Venture |
Amarjit Gill Andy Jacques Breyer Capital Chris Re Clarence So Coatue Management Dennis Wong Jeff Dean Jim Breyer Johnson & Johnson Innovation Koch Disruptive Technologies Lip-Bu Tan Marc Benioff Steve Blank The Factory TIME Ventures Walden Catalyst | undisclosed |
| 02/01/24 | $20,000,000 | Venture |
A&E Investment EDBI Navin Chaddha Prosperity7 Ventures Rajiv Khemani Trium Ventures Walden Catalyst Wilson, Sonsini, Goodrich and Rosati | undisclosed |
| 12/03/25 | $65,000,000 | Growth |
Health Velocity Capital Heritage Medical Systems Jackson Square Ventures Lead Edge Capital  Summation Health Ventures | undisclosed |
